Kalydeco Medication Information
Adults and children as young as six years old may receive a medication called KalydecoTM (ivacaftor) to treat cystic fibrosis. Clinical studies have shown that this prescription drug can help improve lung function, lessen symptoms, cause weight gain, and decrease the risk for pulmonary exacerbations. Although this can be an effective medicine for many people, it is only approved for use in those who have a specific type of gene mutation known as the G551D mutation.
Kalydeco comes as tablets that are taken once a day, twice a day, or twice a week, depending on a variety of factors. Your individual dosage will be based on your age, your liver function, and any other drugs you are taking.
Before taking Kalydeco, make sure to review the safety information of the medication with your healthcare provider. For example, you may not be able to use this medicine if you have certain allergies or problems with your liver or kidneys.
(Click Kalydeco for more information on this medication, including how it works, important warnings, and potential side effects.)